INSIGHT Study on Childhood Nephrotic Syndrome Exploring Genetic and Environmental Factors and Disease Progression
Led by The Hospital for Sick Children · Updated on 2022-10-25
1000
Participants Needed
4
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a long-term observational study to understand childhood nephrotic syndrome, focusing on genetic, serologic, and environmental factors that may influence the condition and its progression. This study involves a diverse group of children to explore how various gene and environmental risks contribute to the disease. Participants are recruited mainly from Toronto, Ontario, with plans to include more locations in the future.
The study includes children diagnosed with nephrotic syndrome between the ages of 6 months and 18 years. Both children and their caregivers are asked to provide informed consent, complete questionnaires, and supply biological samples for research purposes. Children with secondary causes of nephrotic syndrome or systemic diseases are not included to ensure the study focuses on primary nephrotic syndrome.
Throughout the study, participants will be followed over time with regular assessments to track disease relapse and progression. Researchers will evaluate the number of relapses, frequency of relapse, steroid dependency, steroid resistance, and any development of chronic kidney disease or end-stage renal disease. Data collection includes questionnaires and biospecimens, helping to understand how nephrotic syndrome evolves and what factors contribute to its course.
CONDITIONS
Brief Title
INSIGHT (Insight Into Nephrotic Syndrome)
Research Team
R
Rulan Parekh, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Signed informed consent and age-appropriate assent
Age between 6 months and 18 years old
Ability to complete questionnaires
You will not qualify if you...
Congenital nephrotic syndrome diagnosed before age 1
Syndromic disease involving multiple organs
Inability to provide consent by primary caregivers
Conditions such as systemic lupus erythematous
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Long-term Monitoring
Duration - Up to several years until study completion
Participants are followed over time to observe disease progression, relapses, and response to treatment through questionnaires and biospecimen collection.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Using a Smartphone App to Help Young Adults with Chronic Kidney Disease Follow the 2024 KDIGO Care Guidelines
ARREST-NEPHROSIS Registry and Biobank for Resistant Nephrotic Syndrome and Focal Segmental Glomerulosclerosis
Long-term Study Collecting Patient Data and Samples to Improve Treatment and Research
Phase 2 Study Evaluating Safety and Effectiveness of Atacicept in Autoimmune Kidney Diseases Including IgA Nephropathy, Primary Membranous Nephropathy, and Nephrotic Syndrome
Study of Anti-Nephrin Autoantibodies in Adults with Idiopathic Nephrotic Syndrome Including MCD, FSGS, and Membranous Nephropathy
Comparing Belimumab Combined with Rituximab Versus Rituximab Alone for Treating Primary Membranous Nephropathy
Follow-up Study of Rituximab Treatment for Nephrotic Syndrome in Children Aged 1 to 18 Years
Mobile Application Support for Diuretic Management in Patients with Kidney-Related Swelling Using the Diuretic Tuner
Database and Biological Sample Collection for Patients with Minimal Glomerular Lesions and Primary Segmental and Focal Hyalinosis Nephrotic Syndrome in Children and Adults
Research on Immune-Mediated Kidney Diseases Including Nephrotic Syndrome and Lupus Nephritis
INSIGHT Study on Childhood Nephrotic Syndrome Exploring Genetic and Environmental Factors and Disease Progression
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
The rationale and design of Insight into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics (INSIGHT): a prospective cohort study of childhood nephrotic syndrome.